Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
Baoqing Liu,1 Xiaoxiang Mao,2,3 Dandan Huang,2,3 Fei Li,1 Nianguo Dong11Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Department of Cardiology, Union Hospital, Tongji Medical...
Main Authors: | Liu B, Mao X, Huang D, Li F, Dong N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/novel-role-of-nlrp3-inflammasome-in-regulation-of-lipogenesis-in-fasti-peer-reviewed-article-DMSO |
Similar Items
-
Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive
by: Mahmoud S. Sabra, et al.
Published: (2023-12-01) -
Intraperitoneal Injection of MCC950 Inhibits the Progression of Myopia in Form-Deprivation Myopic Mice
by: Zhengyu Chen, et al.
Published: (2023-10-01) -
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
by: Zhang C, et al.
Published: (2019-08-01) -
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus
by: Xiaoxiao Wu, et al.
Published: (2024-03-01) -
Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis
by: Guoqing Gong, et al.
Published: (2023-09-01)